Active Ingredient(s): Tolvaptan
FDA Approved: * April 23, 2018
Pharm Company: * OTSUKA PHARM CO LTD
Category: Hyponatremia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Jynarque Overview

Tolvaptan (trade names Samsca, Jinarc, and others) is an aquaretic drug that functions as a selective, competitive vasopressin receptor 2 (V2) antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). Tolvaptan was approved by the U.S. Food and Drug Administration (FDA) on May 19, 2009, and is sold by Otsuka Pharmaceutical Co. under the trade name Samsca. The FDA granted ...

Read more Jynarque Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tolvaptan

Recent Jynarque Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 15mg, 30mg, 45mg, 60mg, 90mg
  • Tablet, Chewable, Tablet, Capsule: 15mg, 30mg, 45mg, 60mg, 90mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Jynarque: (5 results)

Sorted by National Drug Code
  • 59148-082 Jynarque 15 mg Oral Tablet by Otsuka America Pharmaceutical, Inc.
  • 59148-083 Jynarque 30 mg Oral Tablet by Otsuka America Pharmaceutical, Inc.
  • 59148-087 Jynarque Kit by Otsuka America Pharmaceutical, Inc.
  • 59148-088 Jynarque Kit by Otsuka America Pharmaceutical, Inc.
  • 59148-089 Jynarque Kit by Otsuka America Pharmaceutical, Inc.

Other drugs which contain Tolvaptan or a similar ingredient: (2 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA